Clinical Trials Logo
  1. Home
  2. Venous Thromboembolism
  3. NCT03802929

Diagnostic and Prognostic Prediction Models for Chinese Patients With Venous Thromboembolism

Venous Thromboembolism (VTE) Clinical Trial

Official title:
The DOMESTIC Study: Diagnostic and Prognostic Prediction Models for Patients With Venous Thromboembolism in China

Clinical Trial Summary

The objective of this proposal is to develop and validate diagnostic and prognostic (including short-term and long-term prognoses) prediction models for patients with venous thromboembolism (VTE) in China.

Clinical Trial Description

Venous thromboembolism (VTE), which clinically manifests as deep vein thrombosis (DVT) and pulmonary embolism (PE), is one of the leading causes of mortality that need to be accurately diagnosed and effectively managed. Although a number of clinical decision rules in the domain of VTE have been presented in the literature, such as the well-known prediction models developed by Wells and colleagues, the prognostic models to assess VTE recurrence risk in patients who suffered from a VTE or the Pulmonary Embolism Severity Index (PESI) for short-term mortality risk in PE patients, and various other diagnostic models for both DVT and PE. They are few designed for Chinese patients. The primary objective of this proposal is to develop and validate diagnostic and prognostic (including short-term and long-term prognoses) prediction models for patients with VTE in China. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03802929
Study type Observational
Source Shanghai 10th People's Hospital
Contact Dachun Xu, Ph.D
Phone 0086-18917684045
Email xdc77@tongji.edu.cn
Status Recruiting
Phase
Start date June 1, 2019
Completion date December 31, 2024
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03265054 - Evaluation of the Predictive Value of the Microvesicle Coagulo-lytic Balance in the Recurrence of Venous Thrombosis N/A
Completed NCT04141228 - A Study of Hospital Healthcare Use and Cost in Patients in the Hospital With a Venous Thromboembolism (VTE) Treated With Apixaban or Warfarin in the US
Completed NCT01119274 - EUropean Pharmacogenetics of AntiCoagulant Therapy - Phenprocoumon Phase 4
Completed NCT03965741 - Study to Gather Information How Often Venous Thromboembolism Occurs in Prostate Cancer Patients in Sweden and How This Condition is Treated With Blood Thinners
Completed NCT02798471 - Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE) Phase 3
Completed NCT01583218 - Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study) Phase 3
Completed NCT03521908 - A Study to Compare the Risk of a Major Bleeding in Participants Who Received Blood Thinning Medications Following a Blood Clot
Completed NCT02073682 - Cancer Venous Thromboembolism (VTE) Phase 3
Completed NCT03977870 - Identification of New Genetic Markers for the Risk of Recurrence of Venous Thromboembolism by Whole Genome Analysis
Recruiting NCT06057844 - Molecular Imaging of Active Venous Thrombus With Positron Emission Tomography (PET) N/A
Active, not recruiting NCT04243122 - Assessing Feasibility of Thromboprophylaxis With Apixaban in JAK2-positive Myeloproliferative Neoplasm Patients Phase 2
Recruiting NCT02156401 - VTEval Project - Prospective Cohort Studies to Evaluate and Improve Diagnostics, Management Strategies and Risk Stratification in VTE